Basic Search  |  Summaries  |  Advanced Search

Violation Tracker Individual Record

Company: AstraZeneca Pharmaceuticals LP
Current Parent Company: AstraZeneca
Parent at the Time of the Penalty Announcement:  subscribe to see this data field
Penalty: $11,000,000
Year: 2013
Date: March 7, 2013
Offense Group: competition-related offenses
Primary Offense: price-fixing or anti-competitive practices
Violation Description: AstraZeneca agreed to pay $11 million to end-payor plaintiffs to settle litigation alleging it blocked the introduction of a generic version of the hypertension drug Toprol-XL.
Level of Government: federal
Action Type: private litigation
Court: District of Delaware
Civil or Criminal Case: civil
Case ID: 1:06cv71
Case Name: Merado v. Astrazeneca Pharmaceuticals LP et al
Private Lawsuit Resolution Type: settlement
HQ Country of Current Parent: United Kingdom
Ownership Structure of Current Parent: publicly traded
Major Industry of Current Parent: pharmaceuticals
Specific Industry of Current Parent: pharmaceuticals
Source of Data: (click here)
Link to PACER Case Docket (must be logged in): (click here)
Link to Archived Court Document:  subscribe to see this data field
Source Notes: If an online information source is not working, check the Violation Tracker Data Sources page for an updated link.
Current parent company note: Parent-subsidiary relationship is current as of the most recent revision listed in the Update Log.